092040.KS · 아미코젠

South Korea · RS rating 9 · As of 2026-10-14

Price945.00 KRW
1-day change+2.4%
RS rating (overall / 1M / 3M / 12M)9 / 49 / 11 / 3
StageBasing
Composite / Minervini / CANSLIM score24 / 16 / 21
Industry group (rank)Medical-Generic Drugs (76)
EPS growth Q/Q-193.3%
Sales growth Q/Q+9.1%
Distance from 52-week high+75.5%
Market cap (USD)$51.7M
Open South Korea in the interactive screener